A detailed history of Jump Financial, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 21,159 shares of EXEL stock, worth $741,622. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,159
Holding current value
$741,622
% of portfolio
0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.96 - $27.6 $464,651 - $583,988
21,159 New
21,159 $549,000
Q4 2023

Oct 21, 2024

SELL
$19.25 - $24.13 $2.46 Million - $3.08 Million
-127,788 Reduced 79.87%
32,210 $772,000
Q4 2023

Feb 07, 2024

SELL
$19.25 - $24.13 $2.46 Million - $3.08 Million
-127,788 Reduced 79.87%
32,210 $772,000
Q3 2023

Oct 21, 2024

BUY
$19.04 - $22.74 $3.05 Million - $3.64 Million
159,998 New
159,998 $3.5 Million
Q3 2023

Nov 07, 2023

BUY
$19.04 - $22.74 $3.05 Million - $3.64 Million
159,998 New
159,998 $3.5 Million
Q2 2022

Aug 09, 2022

BUY
$17.44 - $23.16 $1.39 Million - $1.85 Million
79,843 New
79,843 $1.66 Million
Q4 2021

Feb 10, 2022

SELL
$15.84 - $21.88 $382,947 - $528,970
-24,176 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$16.3 - $21.14 $394,068 - $511,080
24,176 New
24,176 $511,000
Q2 2021

Aug 13, 2021

SELL
$17.95 - $25.56 $307,860 - $438,379
-17,151 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$20.53 - $25.22 $352,110 - $432,548
17,151 New
17,151 $388,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.3B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.